In another study, the combination of panobinostat and (+)-JQ1 worked to promote apoptosis in MCL cells resistant to ibrutinib, a Bruton tyrosine Kinase (BTK) inhibitor [234]. This evidence concerns the gene BTK and mantle cell lymphoma.